Mastercard Incorporated
NYSE-MA
Company Overview
Mastercard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally. It facilitates the processing of payment transactions, including authorization, clearing, and settlement, as well as delivers other payment-related products and services. The company offers integrated products and value-added services for account holders, merchants, financial institutions, businesses, governments, and other organizations, such as programs that enable issuers to provide consumers with credits to defer payments; prepaid programs and management services; commercial credit and debit payment products and solutions; and payment products and solutions that allow its customers to access funds in deposit and other accounts. It also provides value-added products and services comprising cyber and intelligence solutions for parties to transact, as well as proprietary insights, drawing on principled use of consumer, and merchant data services. In addition, the company offers analytics, test and learn, consulting, managed services, loyalty, processing, and payment gateway solutions for e-commerce merchants. Further, it provides open banking and digital identity platforms services. The company offers payment solutions and services under the MasterCard, Maestro, and Cirrus. Mastercard Incorporated was founded in 1966 and is headquartered in Purchase, New York.
Name
Mastercard Incorporated
CEO
Mr. Michael Miebach
Website
www.mastercard.com
Sector
Financial Services
Year Founded
1966
Profile
Market Cap
$455.78B
EV
$463.59B
Shares Out
923.83M
Revenue
$26.39B
Employees
33,400
Margins
Gross
100%
EBITDA
61.55%
Operating
58.31%
Pre-Tax
55.24%
Net
46.45%
FCF
44.41%
Returns (5Yr Avg)
ROA
26.05%
ROTA
290.21%
ROE
143.01%
ROCE
50.95%
ROIC
40.16%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$519.17
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$7,358M
Net Debt
$7,749M
Debt/Equity
2.09
EBIT/Interest
25.56
Growth (CAGR)
Rev 3Yr
16.62%
Rev 5Yr
10.94%
Rev 10Yr
11.5%
Dil EPS 3Yr
22.04%
Dil EPS 5Yr
15.08%
Dil EPS 10Yr
16.81%
Rev Fwd 2Yr
11.69%
EBITDA Fwd 2Yr
12.99%
EPS Fwd 2Yr
16.33%
EPS LT Growth Est
16.35%
Dividends
Yield
—
Payout
19.45%
DPS
$2.55
DPS Growth 3Yr
14.03%
DPS Growth 5Yr
15.51%
DPS Growth 10Yr
20.66%
DPS Growth Fwd 2Yr
11.84%